Global Peripheral Vascular Stents Market

Global Peripheral Vascular Stents Market Size Insights Forecasts to 2035

• The Global Peripheral Vascular Stents Market Size Was valued at USD 4.28 Billion in 2024
• The Global Peripheral Vascular Stents Market Size is Expected to Grow at a CAGR of around 7.19% from 2025 to 2035
• The Worldwide Peripheral Vascular Stents Market Size is Expected to Reach USD 9.19 Billion by 2035
• Asia-Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Decisions Advisors and Consulting, The Global Peripheral Vascular Stents Market Size Was Worth Around USD 4.28 Billion In 2024 And Is Predicted To Grow To Around USD 9.19 Billion By 2035 With A Compound Annual Growth Rate (CAGR) Of 7.19% From 2025 To 2035. The worldwide occurrence of peripheral artery disease (PAD) and its connection to aging populations and dangerous lifestyle habits and rising diabetes and hypertension rates creates a growing market demand for products.

 

Market Overview

The Peripheral vascular stents serve as small mesh tubular devices which open narrowed or blocked peripheral arteries to enhance blood circulation in patients who suffer from peripheral artery disease (PAD). These stents are commonly placed in arteries outside the heart including the legs arms and neck. The global market for peripheral vascular stents experiences steady growth because cardiovascular disorders become more common and the geriatric population continues to rise and people choose less invasive medical procedures. Healthcare facilities see better clinical results because of new medical technologies which include drug-eluting stents and covered stents and bioresorbable stents. Better healthcare systems together with rising public knowledge about early vascular disease detection and treatment make markets grow in both developed nations and developing countries.

 

Report Coverage

This research report categorizes the peripheral vascular stents market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the peripheral vascular stents market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the peripheral vascular stents market. 

 

Driving Factors

The market experiences growth because of three main factors which include the increasing rate of peripheral artery disease, the aging elderly population, and the rising awareness about cardiovascular health. The adoption of stent technology (which includes drug-eluting and covered and bioresorbable stents) has increased because people prefer to undergo less invasive medical procedures. The market experiences accelerated growth because key regions expand their healthcare facilities and develop better systems to reimburse medical expenses.

 

Restraining Factors

High procedure and device costs together with strict regulatory approval processes and the shortage of qualified healthcare workers in developing areas create obstacles for market expansion. The risk of complications together with the preference for alternative therapies prevent the technology from achieving widespread use.

 

Market Segmentation

The peripheral vascular stents market share is classified into product type and artery type.

 

• The drug-eluting stents segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.           

Based on the product type, the peripheral vascular stents market is divided into self-expanding stents, balloon-expanding stents, covered stents, and drug-eluting stents. Among these, the drug-eluting stents segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Drug-eluting stents demonstrate lower restenosis rates when compared to bare metal stents (BMS). The widespread use of DES exists because of their capability to decrease major adverse cardiac events (MACE) which they accomplish through their design. The stent's drug coating establishes a protective barrier which protects against stent thrombosis and subsequent blood clot development within the stent. The procedure reduces the risk of heart attacks and strokes and other cardiovascular conditions which results in better patient safety and higher survival rates.  

        

• The fem-pop artery segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.     

Based on the artery type, the peripheral vascular stents market is divided into carotid artery, fem-pop artery, iliac artery, and infrapop artery. Among these, the fem-pop artery segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The increased occurrence of peripheral artery disease in older individuals and diabetic patients results in more cases of the disease. The combination of increased demand for minimally invasive endovascular surgeries and improved success rates of medical procedures and ongoing progress in stent technology drives both strong revenue growth and persistent expansion of the market.    

 

Regional Segment Analysis of the Peripheral Vascular Stents Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the Peripheral Vascular Stents market over the predicted timeframe.

North America is anticipated to hold the largest share of the peripheral vascular stents market over the predicted timeframe. North America has developed an advanced healthcare system which includes modern medical facilities and trained medical staff. The infrastructure enables CVD diagnosis and treatment through the distribution of peripheral vascular stents to patients throughout the area.

Asia-Pacific is expected to grow at a rapid CAGR in the peripheral vascular stents market during the forecast period. The increase in population growth happens because people today follow inactive life patterns and eat unhealthy food and the number of elderly citizens keeps rising which causes more people to develop PAD. The need for successful treatment methods has grown because peripheral vascular stents have become essential medical devices. The peripheral vascular stents industry expands because government programs and supportive regional policies create public awareness and disease prevention initiatives and reimbursement systems that help people access advanced medical technologies while improving their heart health.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the peripheral vascular stents market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Medtronic Plc.
• Cardinal Health, Inc.
• B. Braun Melsungen AG
• MicroPort Scientific Corporation
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG
• Abbott Laboratories
• W.L. Gore & Associates Inc.
• Cook Medical Inc.
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the peripheral vascular stents market based on the below-mentioned segments: 

 

Global Peripheral Vascular Stents Market, By Product Type

• Self-Expanding Stents
• Balloon-Expanding Stents
• Covered Stents
• Drug-Eluting Stents

 

Global Peripheral Vascular Stents Market, By Artery Type

• Carotid Artery
• Fem-Pop Artery
• Iliac Artery
• Infrapop Artery

 

Global Peripheral Vascular Stents Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  •  South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

 

Frequently Asked Questions (FAQ)

 

1. What is the CAGR of the peripheral vascular stents market over the forecast period?

A: The global peripheral vascular stents market is projected to expand at a CAGR of 7.19% during the forecast period.

 

2. What is the market size of the peripheral vascular stents market?

A: the global peripheral vascular stents market size is estimated to grow from USD 4.28 Billion in 2024 to USD 9.19 Billion by 2035, at a CAGR of 7.19% during the forecast period 2025-2035.   

 

3. Which region holds the largest share of the peripheral vascular stents market?

A: North America is anticipated to hold the largest share of the Peripheral Vascular Stents market over the predicted timeframe.

 

4. Who are the top 10 companies operating in the global peripheral vascular stents market?

A: Medtronic Plc., Cardinal Health, Inc., B. Braun Melsungen AG, MicroPort Scientific Corporation, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Abbott Laboratories, W.L. Gore & Associates Inc., Cook Medical Inc., and Others

 

5. What are the market trends in the peripheral vascular stents market?

A: The primary trends that drive the market exist through three main factors which include developments in stent design technology and the rising demand for minimally invasive treatments and the increasing cases of peripheral artery disease and better reimbursement systems and the growth of medical facilities in developing nations.